Ignite Creation Date:
2024-05-06 @ 7:51 AM
Last Modification Date:
2024-10-26 @ 11:53 AM
Study NCT ID:
NCT02619630
Status:
RECRUITING
Last Update Posted:
2019-10-21
First Post:
2015-11-25
Brief Title:
Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults 18-59 Years Old
Sponsor:
Assistance Publique - Hôpitaux de Paris
Organization:
Assistance Publique - Hôpitaux de Paris
Study Overview
Official Title:
Multicenter Study of Risk-adapted Treatment for T-lineage ALL of Young Adults 18-59 Years Old Evaluating the Efficacy of a Nelarabine Based Consolidation and Maintenance in High-risk Patients
Status:
RECRUITING
Status Verified Date:
2019-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
GRAALL-2014T
Brief Summary:
The purpose of this study is to evaluate the efficacy of nelarabine-based consolidation and maintenance therapy in term of relapse-free survival RFS in high-risk HR patients
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None